CAS: 914088-09-8 - Brentuximab vedotin

Formel: Unspecified

Synonyme:

• cAC10-vcMMAE
• Brentuximab vedotin
• SGN 35
• Immunoglobulin G1, anti-(human CD30 (antigen)) (human-mouse monoclonal cAC10 γ1-chain), disulfide with human-mouse monoclonal cAC10 κ-chain, dimer, complex with N-[[[4-[[N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
• CAC10-vcMMAE

Brentuximab vedotin

CAS: 914088-09-8

Brentuximab vedotin (SGN-35) is an antibody-activated molecule coupling (ADC) targeting CD30 with antitumor activity for …

• Reinheit: 95% - 97.73% (SEC-HPLC)
• Farbe und Form: Solid
• Molekulargewicht: 145.58 kDa

Brentuximab vedotin

CAS: 914088-09-8

Antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE).